BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8443598)

  • 1. Modulation of antibody affinity by a non-contact residue.
    Schillbach JF; Near RI; Bruccoleri RE; Haber E; Jeffrey PD; Novotny J; Sheriff S; Margolies MN
    Protein Sci; 1993 Feb; 2(2):206-14. PubMed ID: 8443598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10.
    Schildbach JF; Near RI; Bruccoleri RE; Haber E; Jeffrey PD; Ng SC; Novotny J; Sheriff S; Margolies MN
    J Biol Chem; 1993 Oct; 268(29):21739-47. PubMed ID: 7691815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.
    Schildbach JF; Shaw SY; Bruccoleri RE; Haber E; Herzenberg LA; Jager GC; Jeffrey PD; Panka DJ; Parks DR; Near RI
    Protein Sci; 1994 May; 3(5):737-49. PubMed ID: 8061604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
    Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
    J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered hapten recognition by two anti-digoxin hybridoma variants due to variable region point mutations.
    Schildbach JF; Panka DJ; Parks DR; Jager GC; Novotny J; Herzenberg LA; Mudgett-Hunter M; Bruccoleri RE; Haber E; Margolies MN
    J Biol Chem; 1991 Mar; 266(7):4640-7. PubMed ID: 1999439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying specificity of antidigoxin antibodies using insertional mutagenesis.
    Krykbaev RA; Tsantili P; Jeffrey PD; Margolies MN
    Protein Sci; 2002 Dec; 11(12):2899-908. PubMed ID: 12441388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage display-selected sequences of the heavy-chain CDR3 loop of the anti-digoxin antibody 26-10 define a high affinity binding site for position 16-substituted analogs of digoxin.
    Krykbaev RA; Liu WR; Jeffrey PD; Margolies MN
    J Biol Chem; 2001 Mar; 276(11):8149-58. PubMed ID: 11060305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary combining site contact residue mutations of the anti-digoxin Fab 26-10 permit high affinity wild-type binding.
    Short MK; Krykbaev RA; Jeffrey PD; Margolies MN
    J Biol Chem; 2002 May; 277(19):16365-70. PubMed ID: 11854275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A spontaneous variant of an antidigoxin hybridoma antibody with increased affinity arises from a heavy chain signal peptide mutation.
    Shaw SY; Margolies MN
    Mol Immunol; 1992 Apr; 29(4):525-9. PubMed ID: 1565100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an anti-digoxin antibody binding site by site-directed in vitro mutagenesis.
    Near RI; Mudgett-Hunter M; Novotny J; Bruccoleri R; Ng SC
    Mol Immunol; 1993 Mar; 30(4):369-77. PubMed ID: 8455637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of antibody affinity by an engineered amino acid substitution.
    Wong YW; Kussie PH; Parhami-Seren B; Margolies MN
    J Immunol; 1995 Apr; 154(7):3351-8. PubMed ID: 7897218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and structural diversity among high-affinity monoclonal anti-digoxin antibodies.
    Mudgett-Hunter M; Anderson W; Haber E; Margolies MN
    Mol Immunol; 1985 Apr; 22(4):477-88. PubMed ID: 4033667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multinuclear NMR study of the affinity maturation of anti-NP mouse monoclonal antibodies: comparison of antibody combining sites of primary response antibody N1G9 and secondary response antibody 3B62.
    Nakayama T; Arata Y; Shimada I
    Biochemistry; 1993 Dec; 32(50):13961-8. PubMed ID: 8268173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of antibody A6 binding to the extracellular interferon gamma receptor alpha-chain by alanine-scanning mutagenesis and random mutagenesis with phage display.
    Lang S; Xu J; Stuart F; Thomas RM; Vrijbloed JW; Robinson JA
    Biochemistry; 2000 Dec; 39(51):15674-85. PubMed ID: 11123892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regeneration of antidigoxin binding activity in an antibody by changes surrounding the original binding defect.
    Hudson NW; Albrecht M; Randhawa ZI; Steinrauf LK; Hamilton JA
    Mol Immunol; 1993 May; 30(7):685-93. PubMed ID: 8487784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of a sequence-specific ssDNA binding lupus autoantibody.
    Cleary J; Glick GD
    Biochemistry; 2003 Jan; 42(1):30-41. PubMed ID: 12515537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation of binding site geometry among p-azophenylarsonate-specific antibodies.
    Parhami-Seren B; Kussie PH; Strong RK; Margolies MN
    J Immunol; 1993 Mar; 150(5):1829-37. PubMed ID: 8436818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of peptidic mimics of digoxin from phage-displayed peptide libraries by anti-digoxin antibodies.
    Ball WJ; Wang Z; Malik B; Kasturi R; Dey P; Short MK; Margolies MN
    J Mol Biol; 2000 Aug; 301(1):101-15. PubMed ID: 10926495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.